For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes.
Scope of the Report:
For the API product, there are many manufacturers in India, China, and Europe, such as Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, CR Double-Crane and Keyuan Pharmaceutical. Among them, Wanbury and USV are global leading manufacturers with capacity nearly 10000 MT relatively.
Global Metformin hydrochloride consumption is mainly concentrated in Asia Pacific. In 2018, Asia Pacific Metformin hydrochloride consumption took about 61.30%. Followed by Europe with sales share of 14.98%.
The worldwide market for Metformin Hydrochloride is expected to grow at a CAGR of roughly 4.5% over the next five years, will reach 340 million US$ in 2024, from 280 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Metformin Hydrochloride in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Wanbury
- USV
- Shouguang Fukang Pharmaceutical
- Vistin Pharma
- CR Double-Crane
- Keyuan Pharmaceutical
- Farmhispania Group
- Harman Finochem
- Shijiazhuang Polee Pharmaceutical
- Aarti Drugs
- Exemed Pharmaceuticals
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Metformin HCL
- Metformin DC
Market Segment by Applications, can be divided into
- Metformin Hydrochloride Tablets
- Metformin Hydrochloride Extended-Release Tablets
- Others form
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metformin Hydrochloride product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metformin Hydrochloride, with price, sales, revenue and global market share of Metformin Hydrochloride in 2017 and 2018.
Chapter 3, the Metformin Hydrochloride competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metformin Hydrochloride breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Metformin Hydrochloride market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Metformin Hydrochloride sales channel, distributors, customers, research findings and conclusion, appendix and data source.